Murray Esler

Active 1973–2024

182
Papers
37,195
Citations
112
h-index
178
i10-index

Citations

Citations per year for Murray Esler1974: 2 citations1975: 5 citations1976: 7 citations1977: 11 citations1978: 17 citations1979: 14 citations1980: 8 citations1981: 18 citations1982: 20 citations1983: 22 citations1984: 25 citations1985: 15 citations1986: 22 citations1987: 33 citations1988: 44 citations1989: 46 citations1990: 31 citations1991: 41 citations1992: 52 citations1993: 68 citations1994: 48 citations1995: 77 citations1996: 61 citations1997: 99 citations1998: 97 citations1999: 144 citations2000: 180 citations2001: 176 citations2002: 138 citations2003: 192 citations2004: 131 citations2005: 178 citations2006: 158 citations2007: 209 citations2008: 212 citations2009: 262 citations2010: 270 citations2011: 324 citations2012: 372 citations2013: 356 citations2014: 367 citations2015: 284 citations2016: 190 citations2017: 163 citations2018: 160 citations2019: 663 citations2020: 689 citations2021: 538 citations2022: 376 citations2023: 383 citations2024: 532 citations2025: 238 citations2026: 6 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,289 citing papers, 29.6% of this breakdownUnited Kingdom: 545 citing papers, 7% of this breakdownAustralia: 516 citing papers, 6.7% of this breakdownItaly: 498 citing papers, 6.4% of this breakdownGermany: 466 citing papers, 6% of this breakdownChina: 353 citing papers, 4.6% of this breakdownCanada: 299 citing papers, 3.9% of this breakdownJapan: 263 citing papers, 3.4% of this breakdownNetherlands: 222 citing papers, 2.9% of this breakdownFrance: 165 citing papers, 2.1% of this breakdownSpain: 149 citing papers, 1.9% of this breakdownSweden: 148 citing papers, 1.9% of this breakdown
0%29.6%Other 23.6%

Fields

  • Medicine74.4%
  • Neuroscience12.6%
  • Biochemistry, Genetics and Molecular Biology5.6%
  • Psychology2.3%
  • Nursing1.4%
  • Health Professions0.7%
  • Other3%

Topics

  • Heart Rate Variability and Autonomic Control10.7%
  • Blood Pressure and Hypertension Studies6.4%
  • Cardiovascular and exercise physiology2.5%
  • Stress Responses and Cortisol2.3%
  • Hormonal Regulation and Hypertension2.2%
  • Cardiovascular Syncope and Autonomic Disorders2.1%
  • Other73.8%

Coauthors

All papers

Open in search
  1. Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , George K. Dresser, Michel Vallée, Shivinder Jolly, S. P. Chow, Ji‐Guang Wang, Jianjun Mu, Jing Yu, Hong Yuan, Yingqing Feng, Xin Zhang, Jianhong Xie, Ling Lin, Miroslav Souček, J Widimský, Renata Cífková, J. Václavík, Martin Ullrych, Martin Lukáč, Ivan Rychlík, Thomas Guldager Lauridsen, Ilkka Kantola, Jyrki Taurio, Olavi Ukkola, Olivier Ormezzano, Philippe Gosse, Michel Azizi, Pierre‐Yves Courand, Pascal Delsart, Jean Michel Tartiere, Felix Mahfoud, Roland E. Schmieder, Johannes Stegbauer, Philipp Lurz, Michael Koziolek, Christian Ott, Nicole Toursarkissian, Konstantinos Tsioufis, K. Kyfnidis, Athanasios Manolis, Sotirios Patsilinakos, Pantelis Zebekakis, Apostolos Karavidas, Pall Denes, Katalin Bezzegh, Marianna Zsom, László Kovács, Yehonatan Sharabi, Mazen Elias, Ivetta Sukholutsky, Chaim Yosefy, Irina Kenis, Shaul Atar, Massimo Volpe, Muiesan Maria Lorenza, Stefano Taddei, Guıdo Grassı, Franco Veglio, Jung‐Woo Son, Jang‐Young Kim, Joong-Il Park, Chang Hoon Lee, Hae‐Young Lee, Rasa Raugalienė, Jolanta Elena Marcinkeviciene, Roma Kavaliauskiene, Jaap Deinum, Abraham A. Kroon, Bert‐Jan H. van den Born, Andrzej Januszewicz, Andrzej Tykarski and 115 more - The Lancet 2022 cited by 227

  2. The Sympathetic Nervous System Alterations in Human Hypertension

    Authors: , , - Circulation Research 2015 cited by 591

  3. Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Herbert D. Aronow, Anvar Babaev, Keith Benzuly, Somjot Brar, David L. Brown, David A. Calhoun, Paul N. Casale, Sheldon Chaffer, James W. Choi, Eugene H. Chung, Debbie L. Cohen, Mark A. Creager, George Dangas, Harold L. Dauerman, Shukri David, Mark G. Davies, Eduardo de Marchena, Ali E. Denktas, Chandan Devireddy, William Downey, Mark E. Dunlap, Daniel S. Fisher, John M. Flack, Magdi Ghali, Eric Gnall, Raghava Gollapudi, Mark A. Goodwin, Nilesh Goswami, Luis Gruberg, Rajiv Gulati, Anuj Gupta, Anjan Gupta, Hitinder S. Gurm, Jeffrey L. Hastings, Scott Kinlay, Robert Kipperman, Maurice Buchbinder, Ajay J. Kirtane, Richard Kovach, David Lee, Samuel J. Mann, Steven P. Marso, Fadi Matar, Ernest L. Mazzaferri, Farrel Mandelsohn, Issam Moussa, Timothy F. Murphy, Sandeep Nathan, B J Negus, Sahil A. Parikh, Manesh R. Patel, Kirikumar Patel, Basil Paulus, George Petrossian, Alex Powell, J Preibisz, Florian Rader, Otelio S. Randall, Mahmood K. Razavi, John P. Reilly, Jonathan Reiner, Michael Ring, Mark Robbins, Kevin Rogers, Nicolas Ruggiero, Renato Nakagawa Santos, William C. Little, John Schindler, T Scott, Thomas Shimshak and 15 more - The Lancet 2022 cited by 176

  4. Catheter-Based Renal Denervation: 9-Year Follow-Up Data on Safety and Blood Pressure Reduction in Patients With Resistant Hypertension

    Authors: , , , , , , , , , , , , , - Hypertension 2023 cited by 82

  5. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study

    Authors: , , , , , , , , , , , - The Lancet 2009 cited by 2,105

  6. Clinical neurocardiology defining the value of neuroscience‐based cardiovascular therapeutics

    Authors: , , , , , , , , , , , , , , , , , , , , - The Journal of Physiology 2016 cited by 314

  7. Individualized Beta-Blocker Treatment for High Blood Pressure Dictated by Medical Comorbidities: Indications Beyond the 2018 European Society of Cardiology/European Society of Hypertension Guidelines

    Authors: , , , , , - Hypertension 2022 cited by 80

  8. Predictors of blood pressure response in the SYMPLICITY HTN-3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2014 cited by 540

  9. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study

    Authors: , , , , , , , - The Lancet 2013 cited by 622

  10. Sympathetic Augmentation in Hypertension

    Authors: , , , , , , , , - Hypertension 2003 cited by 512

  11. Renal Denervation in Moderate to Severe CKD

    Authors: , , , , , , , , , , - Journal of the American Society of Nephrology 2012 cited by 354

  12. The sympathetic system and hypertension*1

    Authors: - American Journal of Hypertension 2000 cited by 478

  13. Translational medicine: the antihypertensive effect of renal denervation

    Authors: , - American Journal of Physiology-Regulatory, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2009 cited by 428

  14. Human ageing and the sympathoadrenal system

    Authors: , - The Journal of Physiology 2000 cited by 403

  15. Renal Sympathetic-Nerve Ablation for Uncontrolled Hypertension

    Authors: , , , , - New England Journal of Medicine 2009 cited by 775

  16. Relation Between Cardiac Sympathetic Activity and Hypertensive Left Ventricular Hypertrophy

    Authors: , , , , , - Circulation 2003 cited by 454

  17. Characterization of Cardiac Sympathetic Nervous System and Inflammatory Activation in HFpEF Patients

    Authors: , , , , , , , - JACC Basic to Translational Science 2022 cited by 50

  18. Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover.

    Authors: , , , , , , , - Hypertension 1988 cited by 641

  19. Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant Hypertension

    Authors: , , , , , , , , , , , , - Circulation 2011 cited by 570

  20. Renal Sympathetic Denervation for Treatment of Drug-Resistant Hypertension

    Authors: , , , , , - Circulation 2012 cited by 464

  21. The global burden of hypertension exceeds 1.4 billion people

    Authors: , , , , - Journal of Hypertension 2019 cited by 202

  22. Mental stress and human cardiovascular disease

    Authors: - Neuroscience & Biobehavioral Reviews 2016 cited by 199

  23. How to assess sympathetic activity in humans

    Authors: , - Journal of Hypertension 1999 cited by 450

  24. Cardiac Sympathetic Nerve Function in Congestive Heart Failure

    Authors: , , , , , , , , - Circulation 1996 cited by 450